Boston Scientific Acquires Devoro Medical
September 21, 2021
Boston Scientific agreed to acquire the remaining 84% of Devoro Medical, developer of the WOLF Thrombectomy Platform, paying approximately $269 million upfront plus up to $67 million in milestone payments. Boston Scientific had been a strategic investor in Devoro since 2019 (holding ~16%); the acquisition expands Boston Scientific’s clot-management and peripheral interventions product portfolio by adding a non-console, lytic-free thrombectomy technology.
- Targets
- Devoro Medical, Inc.
- Industry
- Medical Devices
- Location
- United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Boston Scientific Makes $1.5 Billion Investment in MiRus LLC for Option to Acquire TAVR Business
May 18, 2026
Medical Devices
Boston Scientific Corporation invested $1.5 billion for an approximately 34% equity stake in privately held MiRus LLC. Under the investment agreement, Boston Scientific received an exclusive option to acquire MiRus’s SIEGEL balloon-expandable TAVR system business for up to $3 billion in additional cash payments, subject to clinical and regulatory milestones and closing conditions.
-
Boston Scientific To Acquire Penumbra, Inc. for About $14.5 Billion
January 16, 2026
Medical Devices
Boston Scientific signed a definitive agreement to acquire Penumbra, Inc. in a cash-and-stock transaction valued at about $14.5 billion on an enterprise value basis. The deal is designed to broaden Boston Scientific’s vascular and neurovascular portfolio, particularly in mechanical thrombectomy and adjacent neurovascular markets, with expected closing in 2026 subject to regulatory approvals and Penumbra shareholder approval.
-
Thermo Fisher Scientific to Acquire Clario Holdings
October 29, 2025
Healthcare Services
Thermo Fisher Scientific has agreed to acquire Clario Holdings, a digital clinical endpoint data solutions company, for $8.875 billion in cash plus up to $400 million in performance-based earnout payments. The deal is expected to close by mid-2026 pending regulatory approvals and would integrate Clario into Thermo Fisher’s Laboratory Products and Biopharma Services segment.
-
Boston Scientific Agrees to Acquire Bolt Medical
January 8, 2025
Medical Devices
Boston Scientific Corporation entered into a definitive agreement to acquire Bolt Medical, Inc., developer of an intravascular lithotripsy (IVL) laser-based platform for treating calcified coronary and peripheral artery disease. The deal includes an upfront payment of about $443 million for the 74% stake Boston Scientific does not already own, plus up to $221 million tied to regulatory milestones.
-
SARIA Acquires Devro for £540 Million
November 27, 2022
Food & Beverage
SARIA SE & Co. KG has agreed to acquire Scotland-based collagen casing maker Devro for £540 million. The purchase will combine SARIA’s existing casing activities with Devro’s global manufacturing footprint to broaden product offerings, increase scale and accelerate long-term sustainable growth.
-
Surmodics Acquires Vetex Medical Limited
July 6, 2021
Medical Devices
Surmodics, Inc. (NASDAQ: SRDX) acquired Galway-based Vetex Medical Limited to expand its thrombectomy portfolio with the ReVene Thrombectomy Catheter. The deal included an upfront payment of $39.9 million and up to $7 million in additional milestone payments (with $3.5 million guaranteed), giving Surmodics a second FDA 510(k)-cleared mechanical thrombectomy device and IP to accelerate its thrombectomy platform development.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.